Abstract: Nozzles (22) for reducing noise generated by the release of gas from a hazard suppression system (10) are provided. The nozzles (22) comprise a plurality of partitions (42, 44, 46, 48) that define a serpentine gas flow path through the nozzle. The flow path causes the gas to undergo a plurality of expansions and directional changes thereby reducing the velocity of the gas and dampening the generation of sound waves as the gas exits the nozzle (22) through the nozzle outlet (40).

Abstract: A valve for controlling flow of pressurized fluid from a confined area that is operable to relieve an overpressure condition as well as to allow flow of fluid in response to a pressure relief command. The valve including a valve body with a fluid passage therethrough, a reverse buckling rupture disc in the valve body in normally blocking relationship to the flow of fluid through the passage, and a selectively actuatable device carried by the valve body adjacent the convex surface. The actuatable device is operable to disrupt, without puncturing, the disc so as to initiate reversal and rupture of the disc and to permit flow of the pressurized fluid through the passage.

Abstract: A valve for controlling flow of pressurized fluid from a confined area that is operable to relieve an overpressure condition as well as to allow flow of fluid in response to a pressure relief command. The valve including a valve body with a fluid passage therethrough, a reverse buckling rupture disc in the valve body in normally blocking relationship to the flow of fluid through the passage, and a selectively actuatable device carried by the valve body adjacent the convex surface. The actuatable device is operable to disrupt, without puncturing, the disc so as to initiate reversal and rupture of the disc and to permit flow of the pressurized fluid through the passage.

Abstract: Disclosed are medical devices comprising one or more surfaces, one or more SAM molecules attached to the one or more surfaces of the medical device, and one or more therapeutic agents attached to the one or more self-assembled monolayer molecules. Also disclosed are medical devices comprising one or more surfaces, one or more self-assembled monolayer molecules attached to the one or more surfaces of the medical device, one or more linkers comprising a first functional group and a second functional group, the first functional group attached to the self-assembled monolayer molecule and a therapeutic agent attached to the second functional group. The therapeutic agent may be attached to the SAM molecule via a linker. The present invention also concerns methods of administering a therapeutic agent to a subject, comprising contacting the subject with one of the medical devices set forth herein.